Group 2 Pulmonary Hypertension: Clinical Trials

1 trial for Group 2 Pulmonary Hypertension, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1

Follow Group 2 Pulmonary Hypertension: new trials by email Literature Review of Group 2 Pulmonary Hypertension trials Research Report on Group 2 Pulmonary Hypertension

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension
JK07 - HFrEF - Heart Failure With Reduced Ejection Fraction, HFpEF - Heart Failure With Preserved Ejection Fraction
Phase 2WithdrawnSalubris Biotherapeutics Inc2025-12-152026-05-15

Narrower conditions

Fibromatosis, Gingival, 2 (1)  ·  Heart Failure (1)  ·  Heart Failure, Diastolic (1)  ·  Heart Failure, Systolic (1)  ·  Hypertension, Pulmonary (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Hypertension (1)  ·  Lung Diseases (1)  ·  Respiratory Tract Diseases (1)  ·  Vascular Diseases (1)

Sponsors

Salubris Biotherapeutics Inc (1)

Countries

United States (1)